Published in Health Business Week, September 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Baxa Corporation.
Report 1: Baxa Corporation and Health Robotics announce a strategic alliance to automate the preparation of patient-specific chemotherapy drug admixtures. Under the agreement, Health Robotics will optimize its technology for the exclusive use of the Baxa Two-Fer(TM) Needles in the automated vial and final containers' access steps for its CytoCare(TM) Robot. Baxa Two-Fer Needles provide a unique design that can be used for vented or non-vented vial access. Their Huber tip prevents...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.